BMI View: While Bangladesh’s ambitious goals for pharmaceutical exports are unlikely to be realised, the
sector will see modest growth ahead. Emerging markets such as Myanmar will be stable sources of demand
even as opportunities to export to the lucrative developed markets such as the US and the EU grow due to
cost containment. A key risk to this stems from the commoditisation of the generic drug sector, which will
place pressure on profit margins, and the competition from the more established Indian pharmaceutical
sector.
Headline Expenditure Projections
? Pharmaceuticals: BDT171.6bn (USD2.2bn) in 2015 to BDT190.8bn (USD2.4bn) in 2016; +11.2% in
local currency terms and +9.1% in US dollar terms.
? Healthcare: BDT494.0bn (USD6.3bn) in 2015 to BDT554.9bn (USD7.0bn) in 2016; +12.3% in local
currency terms and +10.3% in US dollar terms.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Bangladesh 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bangladesh 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Bangladesh 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Bangladesh 2014-2020) 28
Pharmaceuticals & Healthcare Risk/Reward Index 29
Asia Pacific Risk/Reward Index 29
Bangladesh Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Table: Steps To Establish A Pharmaceutical Manufacturing Unit And Obtain A Drug Manufacturing Licence 39
Intellectual Property Issues 39
Pricing And Reimbursement Regime 41
Market Overview 44
Healthcare Sector 44
Healthcare Infrastructure 51
Table: Healthcare Resources (Bangladesh 2010-2015) 51
Table: Healthcare Personnel (Bangladesh 2010-2015) 51
Table: Healthcare Activity (Bangladesh 2010-2015) 52
Research And Development 53
Table: Suggestions Made By University Of Dhaka's Faculty Of Pharmacy To Improve Pharmaceutical Research 54
Clinical Trials 55
Epidemiology 56
Competitive Landscape 59
Research-Based Industry 59
Table: Table: Multinational Market Activity 62
Pharmaceutical Distribution 63
Company Profile 64
Beximco Pharmaceuticals 64
Eskayef 67
Renata 70
Sanofi 73
Square Pharmaceuticals 76
Demographic Forecast 79
Table: Population Headline Indicators (Bangladesh 1990-2025) 80
Table: Key Population Ratios (Bangladesh 1990-2025) 80
Table: Urban/Rural Population & Life Expectancy (Bangladesh 1990-2025) 81
Table: Population By Age Group (Bangladesh 1990-2025) 81
Table: Population By Age Group % (Bangladesh 1990-2025) 82
Glossary 84
Methodology 86
Pharmaceutical Expenditure Forecast Model 86
Healthcare Expenditure Forecast Model 86
Notes On Methodology 87
Risk/Reward Index Methodology 88
Index Overview 89
Table: Pharmaceutical Risk/Reward Index Indicators 89
Indicator Weightings 90

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Bangladesh 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bangladesh 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2012-2020)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020)
Table: Pharmaceutical Trade Data And Forecasts (Bangladesh 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Bangladesh 2014-2020)
Table: Steps To Establish A Pharmaceutical Manufacturing Unit And Obtain A Drug Manufacturing Licence
Table: Healthcare Resources (Bangladesh 2010-2015)
Table: Healthcare Personnel (Bangladesh 2010-2015)
Table: Healthcare Activity (Bangladesh 2010-2015)
Table: Suggestions Made By University Of Dhaka's Faculty Of Pharmacy To Improve Pharmaceutical Research
Table: Table: Multinational Market Activity
Table: Population Headline Indicators (Bangladesh 1990-2025)
Table: Key Population Ratios (Bangladesh 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Bangladesh 1990-2025)
Table: Population By Age Group (Bangladesh 1990-2025)
Table: Population By Age Group % (Bangladesh 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators